ABLAZE PHARMACEUTICALS

ablaze-pharmaceuticals-logo

Ablaze Pharma is a clinical stage bio-pharmaceutical company that is focused on developing Targeted Radiotherapy (TRT) to benefit cancer patients.

#SimilarOrganizations #People #Financial #Website #More

ABLAZE PHARMACEUTICALS

Industry:
Biotechnology Medical Pharmaceutical

Founded:
2011-04-01

Address:
Jingan, Shanghai, China

Country:
China

Website Url:
http://www.ablazepharma.com

Status:
Active

Total Funding:
75 M USD

Technology used in webpage:
Microsoft Exchange Online Office 365 Mail


Similar Organizations

context-therapeutics-logo

Context Therapeutics

Context Therapeutics is a clinical-stage biopharmaceutical company.

leap-therapeutics-logo

Leap Therapeutics

Leap Therapeutics is a clinical-stage biopharmaceutical company.

mediprint-ophthalmics-logo

MediPrint Ophthalmics

MediPrint Ophthalmics is a clinical stage eye care pharmaceutical company.


Current Advisors List

not_available_image

Alex Qiao Board Member @ Ablaze Pharmaceuticals
Board_member

hongbo-lu_image

Hongbo Lu Board Member @ Ablaze Pharmaceuticals
Board_member

benjamin-qiu_image

Benjamin Qiu Board Member @ Ablaze Pharmaceuticals
Board_member

aaron-royston_image

Aaron Royston Board Member @ Ablaze Pharmaceuticals
Board_member

Current Employees Featured

ken-song_image

Ken Song
Ken Song Chairman of the Board and Co-founder @ Ablaze Pharmaceuticals
Chairman of the Board and Co-founder
2021-04-01

not_available_image

Alex Qiao
Alex Qiao President & CEO @ Ablaze Pharmaceuticals
President & CEO
2021-04-01

xu-ming_image

Xu Ming
Xu Ming COO @ Ablaze Pharmaceuticals
COO

Founder


ken-song_image

Ken Song

Investors List

nan-fung-life-sciences_image

Nan Fung Life Sciences

Nan Fung Life Sciences investment in Series A - Ablaze Pharmaceuticals

vivo-capital_image

Vivo Capital

Vivo Capital investment in Series A - Ablaze Pharmaceuticals

venrock-healthcare-partners_image

Venrock Healthcare Capital Partners

Venrock Healthcare Capital Partners investment in Series A - Ablaze Pharmaceuticals

pivotal-bioventure-partners-china_image

Pivotal bioVenture Partners China

Pivotal bioVenture Partners China investment in Series A - Ablaze Pharmaceuticals

samsara-biocapital_image

Samsara BioCapital

Samsara BioCapital investment in Series A - Ablaze Pharmaceuticals

advantech-capital_image

Advantech Capital

Advantech Capital investment in Series A - Ablaze Pharmaceuticals

venbio_image

venBio Partners

venBio Partners investment in Series A - Ablaze Pharmaceuticals

rayz-investments_image

RAYZ Investments

RAYZ Investments investment in Series A - Ablaze Pharmaceuticals

Official Site Inspections

http://www.ablazepharma.com Semrush global rank: 5.95 M Semrush visits lastest month: 1.38 K

  • Host name: a2aa9ff50de748dbe.awsglobalaccelerator.com
  • IP address: 3.33.130.190
  • Location: Seattle United States
  • Latitude: 47.6348
  • Longitude: -122.3451
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98109

Loading ...

More informations about "Ablaze Pharmaceuticals"

Ablaze Pharmaceuticals (US) - life-sciences-usa.com

Jan 1, 2021 BIO (US) (Biotechnology Innovation Organization, formerly Biotechnology Industry Organization) France Biotech; Life Science Washington; Virginia Biotechnology Organisation …See details»

Ablaze Pharmaceuticals - Crunchbase Company Profile …

Organization. Ablaze Pharmaceuticals . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. …See details»

Ablaze Pharmaceuticals - LinkedIn

Ablaze Pharmaceuticals is a clinical-stage pharmaceutical company with a mission to bring advanced targeted radiopharmaceutical therapies (TRT) to benefit cancer patients in China.See details»

Ablaze Pharmaceuticals: Contact Details and Business Profile

Ablaze Pharmaceuticals is a clinical-stage pharmaceutical company with a mission to bring advanced targeted radiopharmaceutical therapies (TRT) to benefit cancer patients in China.See details»

艾博兹医药

艾博兹医药See details»

Ablaze Pharmaceuticals. (11/29/21). "Press Release: Ablaze ...

Leveraging its team’s extensive business experience and network in cross-border product development and deal making, Ablaze strives to become the leader and the partner of choice …See details»

Ablaze Pharmaceuticals - Craft

Ablaze Pharmaceuticals is a pharmaceutical company developing targeted radiotherapy against tumor targets. It is focused on radiopharmaceuticals, the same drug conjugate of which can be …See details»

Ablaze Pharmaceuticals | Startup Profile and Investments

Ablaze Pharmaceuticals is a clinical-stage pharmaceutical company founded in 2011 with a mission to revolutionize the targeted radiotherapy landscape in China. The company has …See details»

Ablaze Pharmaceuticals (艾博兹医药(上海)有限公司) - 药物管 …

凭借其团队在跨境产品开发和交易方面的丰富经验和网络,艾博兹医药致力于通过和国内外战略伙伴的合作,成为中国新兴的TRT市场领导者和首选合作伙伴。欲了解更多信息,欢迎访问 …See details»

Ablaze Pharmaceuticals - PitchBook

Ablaze Pharmaceuticals General Information Description. Developer of Targeted Radiotherapy (TRT) Treatments based on clinical stage. The company leverages founders' extensive business experience and network in cross-border product …See details»

Ablaze Pharmaceuticals - VentureRadar

Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and …See details»

Ablaze Pharmaceuticals Shanghai Co., Ltd. - life-sciences-asia.com

Jan 1, 2021 BIO (US) (Biotechnology Innovation Organization, formerly Biotechnology Industry Organization) ASMS (American Society for Mass Spectrometry) Israel Life Science Industry …See details»

艾博兹医药-动脉网 - vbdata.cn

Apr 30, 2021 艾博兹医药是一家临床阶段的生物制药公司,专注于开发靶向同位素治疗 (trt) 产品以造福中国的癌症患者。我们将借助公司创始人在跨境药品开发和交易方面有丰富业务经验和 …See details»

Ablaze Pharmaceuticals Launches with $75m Series A Financing to …

Nov 29, 2021 For more information, please visit www.ablazepharma.com. About Vivo Capital. Founded in 1996, Vivo Capital is a global investment firm focused on healthcare.See details»

Ablaze Pharmaceuticals_艾博兹医药(上海)有限公司_亿欧数据

Apr 30, 2021 亿欧数据为您提供艾博兹医药(上海)有限公司的主营业务、公司简介、企业官网、公司地址、招聘信息、财务信息、融资情况、团队信息、电话号码、招投标信息、专利等多 …See details»

艾博兹医药:硬“核”创新,引领靶向治疗新篇章(一文详解)医药 …

Sep 14, 2024 艾博兹医药成立于2021年,在上海、北京、成都三地设有办公室 ,秉持 “为中国患者提供创新且可及的靶向放射治疗药物” 为自身使命,致力于通过持续创新,提供安全、有效 …See details»

Ablaze Pharmaceuticals Plans Development of Innovative GPC3 …

Ablaze Pharma Mar 31, 2023, 10:00 ET. Share this article. Share to X. Share this article. Share to X. SHANGHAI, March 31, 2023 /PRNewswire/ -- Ablaze Pharmaceuticals, a biotech company …See details»

Ablaze Pharmaceuticals - Overview, News & Similar companies

Dec 25, 2022 Ablaze Pharmaceuticals Plans Development of Innovative GPC3 Targeted Radiopharmaceutical Therapy for Liver Cancer in Greater China SHANGHAI, March 31, 2023 …See details»

Ablaze Pharmaceuticals - Products, Competitors, Financials, …

Oct 23, 2023 For more information, please visit www.ablazepharma.com. Oct 23, 2023. Eckert & Ziegler to Supply Ablaze Pharmaceuticals with Lutetium-177 for Clinical Trials. Apr 3, 2023. …See details»

Trump tariff news: Canada exempt from reciprocal tariffs

Apr 9, 2025 The White House has confirmed to CTV News that Canada is exempt from the 10 per cent baseline reciprocal tariffs it’s imposing on dozens of other countries.See details»

linkstock.net © 2022. All rights reserved